Chat with us
Research Assistance
Online
  • Please enter your first name.

Brazil Diagnostic Enzymes Market Size & Outlook, 2026-2033

The diagnostic enzymes market in Brazil is expected to reach a projected revenue of US$ 251.0 million by 2033. A compound annual growth rate of 6.7% is expected of Brazil diagnostic enzymes market from 2026 to 2033.

  • Clinical Diagnostics
    • Reagents & Assays
      • Diagnostic Enzymes Market Outlook
Revenue, 2025 (US$M)
$150.3
Estimate, 2026 (US$M)
$159.0
Forecast, 2033 (US$M)
$251.0
CAGR, 2026 - 2033
6.7%
Brazil Diagnostic Enzymes Market, 2021-2033 (US$M)

This page contains premium content. Request sample data or start your free trial to explore Horizon.

  • ✔ Access to global market statistics
  • ✔ Access to company profiles
  • ✔ Free use-cases & research insights

No credit card required*

Prism AI by Grand View ResearchFree to try

Ask a question about the diagnostic enzymes market

Every figure cited from GVR research

Brazil diagnostic enzymes market highlights

  • The Brazil diagnostic enzymes market generated a revenue of USD 150.3 million in 2025 and is expected to reach USD 251.0 million by 2033.
  • The Brazil market is expected to grow at a CAGR of 6.7% from 2026 to 2033.
  • In terms of segment, glucose oxidase/glucose dehydrogenase was the largest revenue generating type in 2025.
  • Lactate dehydrogenase is the most lucrative type segment registering the fastest growth during the forecast period.


Diagnostic enzymes market data book summary

Market revenue in 2025USD 150.3 million
Market revenue in 2033USD 251.0 million
Growth rate6.7% (CAGR from 2026 to 2033)
Largest segmentGlucose oxidase/glucose dehydrogenase
Fastest growing segmentLactate dehydrogenase
Historical data2021 - 2024
Base year2025
Forecast period2026 - 2033
Quantitative unitsRevenue in USD million
Market segmentationTaq polymerase, MMLV RT, HIV RT, Hot start Taq pol, UNG, RNase inhibitor, Bst polymerase (LAMP enzyme), PCR Master Mix, Lyophilised Polymerase, T7 RNA polymerase, Cas9 enzyme, Acid phosphatase, Alanine aminotransferase, Alkaline phosphatase, Amylase, Angiotensin converting enzyme, Aspartate aminotransferase, Cholinesterase, Creatinine kinase, Gamma glutamyl transferase, Lactate dehydrogenase, Renin, Glucose oxidase/glucose dehydrogenase, Urease, Lactate oxidase, Horseradish peroxidase, Glutamate oxidase
Key market players worldwideTakara Bio Inc, Promega, Enzo Biochem Inc, Merck KGaA, Thermo Fisher Scientific Inc, Roche, Roche Holding AG ADR, Solis BioDyne, Ampliqon, Yashraj Biotechnology


Other key industry trends

  • In terms of revenue, Brazil accounted for 2.7% of the global diagnostic enzymes market in 2025.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
  • In Latin America, Brazil diagnostic enzymes market is projected to lead the regional market in terms of revenue in 2033.
  • Brazil is the fastest growing regional market in Latin America and is projected to reach USD 251.0 million by 2033.

Brazil's expanding population and healthcare infrastructure are leading to an increased demand for diagnostic services. Enzyme-based diagnostic tests, such as those used in detecting infectious diseases (e.g., HIV, hepatitis), are essential for accurate and timely diagnoses. For instance, the use of enzyme immunoassays (EIAs) for viral infections has gained significant traction

No credit card required*

Publish Date: Sep 18, 2025

Customize the Report

20% free customization

Include
Countries, segments, points
Tailor
To your product definition
Extend
Deeper competitor detail
Or
A fully bespoke study

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Diagnostic Enzymes Market Companies

NameProfile# EmployeesHQWebsite
Roche Holding AG ADRView profile 103,605Grenzacherstrasse 124, Basel, Switzerland, 4070www.roche.com
Merck KGaAView profile 62,345Frankfurter Strasse 250, Darmstadt, HE, Germany, 64293www.emdgroup.com
Thermo Fisher Scientific IncView profile 122,000168 Third Avenue, Waltham, MA, United States, 02451www.thermofisher.com
Takara Bio IncView profile 1,793Nojihigashi 7-4-38 Kusatu, Shiga, Otsu, Japan, 520-0058www.takara-bio.co.jp
RocheView profile 10001+Basel, Basel-Stadt, Switzerland, Europewww.roche.com
PromegaView profile 5001-10000Madison, Wisconsin, United States, North Americawww.promega.com/es
Enzo Biochem IncView profile 190527 Madison Avenue, New York, NY, United States, 10022www.enzo.com
Solis BioDyneView profile 51-100Tartu, Tartumaa, Estonia, Europesolisbiodyne.com
AmpliqonView profile 11-50Odense, Syddanmark, Denmark, Europewww.ampliqon.com
Yashraj BiotechnologyView profile 251-500Mumbai, Maharashtra, India, Asiawww.yashraj.com

Brazil Diagnostic Enzymes Market Outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Diagnostic Enzymes Market Outlook will help companies and investors design strategic landscapes.


Glucose Oxidase/Glucose Dehydrogenase was the largest segment with a revenue share of 9.12% in 2025.

Horizon Databook has segmented the Brazil diagnostic enzymes market based on taq polymerase, mmlv rt, hiv rt, hot start taq pol, ung, rnase inhibitor, bst polymerase (lamp enzyme), pcr master mix, lyophilised polymerase, t7 rna polymerase, cas9 enzyme, acid phosphatase, alanine aminotransferase, alkaline phosphatase, amylase, angiotensin converting enzyme, aspartate aminotransferase, cholinesterase, creatinine kinase, gamma glutamyl transferase, lactate dehydrogenase, renin, glucose oxidase/glucose dehydrogenase, urease, lactate oxidase, horseradish peroxidase, glutamate oxidase covering the revenue growth of each sub-segment from 2021 to 2033.




Brazil's expanding population and healthcare infrastructure are leading to an increased demand for diagnostic services. Enzyme-based diagnostic tests, such as those used in detecting infectious diseases (e.g., HIV, hepatitis), are essential for accurate and timely diagnoses. For instance, the use of enzyme immunoassays (EIAs) for viral infections has gained significant traction

  • Brazil Diagnostic Enzymes Market Type Outlook (Revenue, USD Million , 2021-2033)
    • UNG
    • RNase inhibitor
    • PCR Master Mix
    • Acid phosphatase
    • Alanine aminotransferase
    • Angiotensin converting enzyme
    • Gamma glutamyl transferase
    • Renin
    • Taq polymerase
    • MMLV RT
    • T7 RNA polymerase
    • Cas9 enzyme
    • Alkaline phosphatase
    • Lactate dehydrogenase
    • Glutamate oxidase
    • HIV RT
    • Hot start Taq pol
    • Lyophilised Polymerase
    • Glucose oxidase/glucose dehydrogenase
    • Others
    • Bst polymerase (LAMP enzyme)
    • Amylase
    • Aspartate aminotransferase
    • Cholinesterase
    • Creatinine kinase
    • Urease
    • Lactate oxidase
    • Horseradish peroxidase
  • Brazil Diagnostic Enzymes Market Application Outlook (Revenue, USD Million , 2021-2033)
    • Diabetes
    • Oncology
    • Infectious Diseases
    • Autoimmune Diseases
    • Others
    • Cardiology
    • Nephrology
  • Brazil Diagnostic Enzymes Market Product Outlook (Revenue, USD Million , 2021-2033)
    • Molecular Enzymes
    • Clinical Enzymes
  • Brazil Diagnostic Enzymes Market End Use Outlook (Revenue, USD Million , 2021-2033)
    • Hospitals
    • Clinical Laboratories
    • Other End Users

Reasons to subscribe to Diagnostic Enzymes Market Outlook databook

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Diagnostic Enzymes Market Outlook databook

  • Our clientele includes a mix of Diagnostic Enzymes Market Outlook companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the Brazil Diagnostic Enzymes Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into Brazil Diagnostic Enzymes Market Outlook from 2021 to 2033, including revenue numbers, major trends, and company profiles.

Brazil Diagnostic Enzymes Market, 2021-2033 (US$M)

No Access Stack Chart

Brazil diagnostic enzymes market statistics, by type, 2021-2033 (US$M)

No Access Pie Chart

Brazil diagnostic enzymes market statistics, by type, 2021-2033 (USD Million)

No Access

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more